TUO.MU: Summary for TERUMO CORP. - Yahoo Finance

UK Markets closed


Munich - Munich Delayed price. Currency in EUR
Add to watchlist
32.890.00 (0.00%)
As of 8:09AM CET. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close34.10
Bid33.24 x 14300
Ask34.90 x 13600
Day's range32.89 - 32.89
52-week range32.44 - 38.51
Avg. volume1
Market capN/A
PE ratio (TTM)N/A
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks Small Cap Research4 hours ago

    CTSO: Poised For Strong 2017. Fresenius Deal A Win-Win-Win

    CytoSorbents (CTSO) has had a busy last couple of months leading up to the annual JP Morgan, Biotech Showcase and Medtech Showcase conferences which were held earlier this week in San Francisco and where management took some time to talk to us.  Just prior to the company’s presentation at the Biotech Showcase they announced an expanded agreement with Fresenius and preannounced expected Q4 and FY2016 product sales. Per the January 10th preannouncement, CTSO expects Q4 product sales of ~$2.6M, implying sequential and yoy growth of approximately 21% and 74%, respectively, and marking the sixth straight quarter of record product sales.  Product sales of $2.6M is also almost 16% higher than what we had forecast ($2.2M).

  • TheStreet.com19 days ago

    FTC Allows Abbott to Spin Off Units, Buy St. Jude Medical

    Abbott can now proceed with its $25 billion buy of St. Jude Medical.

  • GuruFocus.com2 years ago

    Hennessy Japan Fund Adds to Existing Stakes in Second Quarter

    Hennessy Japan Fund (Trades, Portfolio) has a highly developed, time-tested investment strategy, looking for arbitrage opportunities between a company’s fundamental value and its market price.